NCT05890287 2023-06-06A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line ChemotherapyTianjin Medical University Cancer Institute and HospitalPhase NA Recruiting60 enrolled